Last updated: 2026-10-12 17:27:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Zhengye Biotechnology Holding Limited (ZYBT) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $1.60, with a market capitalisation of $81.99M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.62 to $8.01. This page covers its latest market performance, valuation, price trends and company information.
$81.99M | |
$1.82 | |
$14.30 | |
$0.62 | |
$1.73 | |
2.60M | |
5.67M | |
-- | |
$8.01 | |
$0.62 | |
-- | |
-- |
Zhengye Biotechnology Holding Limited (ZYBT) is currently trading at $1.60 as of 2026-10-12 17:25:00, down 7.80% ($0.14) from the previous close of $1.73
During today's regular trading session, ZYBT has traded between $0.62 and $14.30, with a trading volume of 2.60M shares. The current price is near the lower end of today's range.
Over the past seven days, Zhengye Biotechnology Holding Limited (ZYBT) moved from $1.26 to $1.60, representing a gain of 26.59% ($0.33).
The stock traded between $1.09 and $2.89 during the period. The latest price is near the lower end of the 7-day range, indicating strong upward.
The average daily volume was 4.39 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 13.2%
ZYBT is currently trading at $1.60, placing it 13.2% of the way from its 52-week low of $0.62 to its 52-week high of $8.01. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing, and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has a diverse range of vaccines, including vaccines for swine, cattle, goats, waterfowl, sheep, poultry, and pets, available in various provincial regions across China and are exported overseas to Vietnam, Pakistan, and Egypt. The company generates maximum revenue from the sale of swine vaccines, followed by poultry and other vaccines.
| Employees | 269 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Zhengye Biotechnology Holding Limited (ZYBT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.